Skip to main content

United Arab Emirates · Drugs and Pharmaceuticals

Supply of Risankizumab 360 MG/2.4 ML (150 MG/ML) Subcutaneous Wearable Injector - 300 EA

Buyer not disclosed

Active

Tender summary

An Invitation for Bid (IFB) has been issued for the supply of 300 Risankizumab 360 MG/2.4 ML (150 MG/ML) Subcutaneous Wearable Injectors in Dubai, UAE. The notice was published on 2026-10-21, with a submission deadline of 2026-10-26. Access to tender details requires login, and the buyer is not disclosed.

Tender Overview

This is an Invitation for Bid (IFB).

The procurement opportunity is in the United Arab Emirates (AE), specifically Dubai.

Scope of Supply

The tender is for the supply of 300 units of Risankizumab 360 MG/2.4 ML (150 MG/ML) Subcutaneous Wearable Injectors.

Important Dates

  • Published Date: 2026-10-21
  • Submission Deadline: 2026-10-26

Important Information

The buyer for this tender has not been disclosed.

Access to the full tender details requires a login.

Buyer
Not disclosed
Country
United Arab Emirates
Category
Drugs and Pharmaceuticals
Closing date
26 October 2026
Updated
22 October 2026

This summary was structured from public source evidence. Deadline interpretation follows the source country's time zone; confirm exact requirements, closing times and amendments in the original notice before acting.

Related active tenders

Supply of Sodium Tetradecyl Sulphate 3% Injection 2ml Vial - 200 UnitsUnited Arab Emirates · closes 26 Oct 2026Supply of Pegcetacoplan 15mg/0.1ml Intravitreal Injection - 12 EAUnited Arab Emirates · closes 26 Oct 2026Supply of Lenvatinib 10 MG/Day - 10 MG x 1 Capsule - 420 EAUnited Arab Emirates · closes 26 Oct 2026

Prepare before responding

Review the supplier prequalification guide and the vendor response guidance. These explain preparation, not eligibility for this specific notice. Follow the original buyer's requirements.